Shares of the biotech company spiked over 18 percent on nearly 1 million shares traded Thursday. The company has reported that it has submitted an Orphan Drug Application to the FDA for KRN5500.
Going forward ... (see research report)
Copyright ® 2013. The Bedford Report. All Rights Reserved.